We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+14.39%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.1B
AUM Growth
+$1.24B
Cap. Flow
-$337M
Cap. Flow %
-2.38%
Top 10 Hldgs %
47.7%
Holding
1,073
New
204
Increased
305
Reduced
367
Closed
195

Sector Composition

Rank Sector Weight
1 Energy 66.33%
2 Financials 6.78%
3 Healthcare 3.78%
4 Consumer Discretionary 3.04%
5 Technology 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVA
251
DELISTED
Covanta Holding Corporation
CVA
$1.57M 0.01%
90,940
+36,130
+66% +$590K
UNP icon
252
Union Pacific
UNP
$183B
$1.57M 0.01%
9,387
-3,283
-26% -$528K
AVB icon
253
AvalonBay Communities
AVB
$27.1B
$1.57M 0.01%
7,806
-404
-5% -$77.2K
EQR icon
254
Equity Residential
EQR
$25.4B
$1.57M 0.01%
20,794
-1,078
-5% -$77.7K
OLED icon
255
Universal Display
OLED
$3.71B
$1.55M 0.01%
10,145
+1,169
+13% +$145K
TSLA icon
256
Tesla
TSLA
$1.24T
$1.53M 0.01%
81,945
+29,490
+56% +$592K
ACOR
257
DELISTED
Acorda Therapeutics
ACOR
$1.53M 0.01%
959
+43
+5% +$77.5K
ORA icon
258
Ormat Technologies
ORA
$6.11B
$1.53M 0.01%
27,715
+11,790
+74% +$654K
KURA icon
259
Kura Oncology
KURA
$922M
$1.52M 0.01%
91,873
+3,974
+5% +$61.2K
INFY icon
260
Infosys
INFY
$45B
$1.51M 0.01%
137,779
+77,340
+128% +$819K
VYGR icon
261
Voyager Therapeutics
VYGR
$187M
$1.5M 0.01%
78,637
+3,394
+5% +$44.2K
CTSH icon
262
Cognizant
CTSH
$21.5B
$1.49M 0.01%
20,613
+4,981
+32% +$349K
GTHX
263
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.49M 0.01%
89,816
+3,885
+5% +$73.7K
TECD
264
DELISTED
Tech Data Corp
TECD
$1.47M 0.01%
14,346
-696
-5% -$68K
MANH icon
265
Manhattan Associates
MANH
$8.97B
$1.46M 0.01%
26,394
-1,668
-6% -$85.3K
MPC icon
266
Marathon Petroleum
MPC
$90.3B
$1.43M 0.01%
23,866
-11,303
-32% -$711K
FOXF icon
267
Fox Factory Holding Corp
FOXF
$776M
$1.38M 0.01%
19,702
-1,277
-6% -$81K
NATI
268
DELISTED
National Instruments Corp
NATI
$1.37M 0.01%
30,845
-2,267
-7% -$103K
EW icon
269
Edwards Lifesciences
EW
$47.6B
$1.37M 0.01%
21,417
-1,326
-6% -$75.7K
PARA
270
DELISTED
Paramount Global Class B
PARA
$1.36M 0.01%
28,647
+7,341
+34% +$358K
CHTR icon
271
Charter Communications
CHTR
$14.7B
$1.33M 0.01%
3,839
-185
-5% -$60.9K
NCNA
272
NuCana
NCNA
$5.37M
$1.32M 0.01%
16
+1
+7% +$69.2K
NAVI icon
273
Navient
NAVI
$774M
$1.32M 0.01%
114,029
-9,223
-7% -$106K
PDLI
274
DELISTED
PDL BioPharma, Inc.
PDLI
$1.31M 0.01%
352,588
+15,222
+5% +$51.4K
CBIO
275
Crescent Biopharma
CBIO
$602M
$1.3M 0.01%
1,042
+45
+5% +$51.5K

Similar funds

ALPS Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, ALPS Advisors held 1,073 positions worth $14.1B, up 9.6% from $12.9B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors's Q1 2019 filing shows 204 new, 305 increased, 367 reduced and 195 closed positions. Its largest new stake was Enovis: 139,847 shares worth $7.14M. The largest sale was Western Gas Partners Lp, an estimated $420M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, up from 62% a quarter earlier, followed by Financials and Healthcare.

  • ALPS Advisors's largest Q1 2019 buy was Enovis: 139,847 shares worth $7.14M.
  • ALPS Advisors added most to Western Midstream Partners in Q1 2019, an estimated $604M increase.
  • ALPS Advisors's biggest Q1 2019 reduction was Andeavor Logistics LP, cutting an estimated $71.7M.
  • ALPS Advisors fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $420M.
  • ALPS Advisors's ten largest holdings make up 48% of its $14.1B portfolio in Q1 2019.
  • ALPS Advisors opened 204 new positions and closed 195 in Q1 2019.
  • ALPS Advisors's portfolio value rose 9.6% quarter-over-quarter to $14.1B.

Based on ALPS Advisors's 13F filing for Q1 2019, filed 1 May 2019.